Tyler A. Longmire

Also affiliated with Bristol-Myers Squibb (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms”.

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4898

N/A

0DataRank · unranked

22 citations

Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, Benjamin H. Durham, Richard P. Koche, Barbara Spitzer +15 more

DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity

Science Advances(2023)10.1126/sciadv.adk1853

N/A

0DataRank · unranked

22 citations

Elisa Bello, Courtney T.S. Kureshi, Michael J. Walsh, Victoria Lippert, Megan T. Hoffman +5 more